Teva Pharmaceutical shares surged for seven straight sessions
Teva Pharmaceutical (NYSE:TEVA) shares rose for seven straight sessions, as the stock closed about 1%
Teva Pharmaceutical (NYSE:TEVA) shares rose for seven straight sessions, as the stock closed about 1%
Hailshadow/iStock via Getty Images The U.S. FDA has approved the first generic version of Novo
The FDA has approved Steqeyma, a biosimilar of Johnson & Johnson’s (NYSE:JNJ) blockbuster drug Stelara.
Hiroshi Watanabe ADRs of Teva Pharmaceutical (NYSE:TEVA) and Sanofi (NASDAQ:SNY) traded higher in the premarket
Summary: Teva Pharmaceutical stock has rebounded from lows, driven by debt reduction, halted price deflation
designer491 Teva Pharmaceutical (NYSE:TEVA) announced that it will divest Teva-Takeda, its business venture in Japan,
Summary: Teva’s stock has risen 105% in two years, outperforming the S&P 500, but it
JHVEPhoto/iStock Editorial via Getty Images Teva (NYSE:TEVA) presented positive data from a Phase 3 study
Neilson Barnard Stanley Druckenmiller’s Duquesne Family Office closed out holdings in News Corp, (NASDAQ:NWSA) (NASDAQ:NWS),
da-kuk Now that Election Day is over, investors will be eager to find out how